Announcements Trials
Browse Landscape

Phase

Phase 2 154Phase 1 107Phase 1/2 69Phase 3 39Phase 2/3 8Phase NA 7Phase EARLY_PHASE1 7Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 2Oligodendroglioma 1Glioma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 2trametinib 1pembrolizumab 1dabrafenib 1Restraint, Physical 1Radiotherapy 1Radiosurgery 1Radiation 1Outcome Assessment, Health Care 1Observational Studies as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Glioblastoma × Temozolomide × Clear all
NCT06625047 2026-04-29

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Mayo Clinic

Phase 4 Completed
30 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT00686725 2017-06-14

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Merck Sharp & Dohme LLC

Phase 4 Completed
99 enrolled 15 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡